MEI Pharma Inc at Evercore ISI HealthCONx Conference Transcript
Hi. Good afternoon, good morning, wherever you are located. I wanted to welcome Dan Gold from MEI Pharma, and we're going to be talking a little bit about the PI3 kinases and the programs that Dan's put together towards oncology.
Questions & Answers
So Dan, I thought maybe you could start off by giving us a kind of a quick overview of MEI, sort of where you came from and kind of current status?
Sure. I'm glad to. Thanks so much for hosting us today, Liisa. It's a pleasure. So we are a San Diego-based public oncology company. Our primary focus, exclusive focus, is in clinical development of novel assets that we think we can bring to bear expertise for unmet medical need.
We currently have 4 candidates in the clinic. While it's not -- it wasn't by choice,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
